Suppr超能文献

一款解决酒精使用问题的参与式健康促进移动应用程序(黎明计划):一项随机对照试验的方案

A Participatory Health Promotion Mobile App Addressing Alcohol Use Problems (The Daybreak Program): Protocol for a Randomized Controlled Trial.

作者信息

Tait Robert J, Kirkman Jessica J L, Schaub Michael P

机构信息

National Drug Research Institute, Faculty of Health Sciences, Curtin University, Perth, Australia.

Hello Sunday Morning, Sydney, Australia.

出版信息

JMIR Res Protoc. 2018 May 31;7(5):e148. doi: 10.2196/resprot.9982.

Abstract

BACKGROUND

At-risk patterns of alcohol use are prevalent in many countries with significant costs to individuals, families, and society. Screening and brief interventions, including with Web delivery, are effective but with limited translation into practice to date. Previous observational studies of the Hello Sunday Morning approach have found that their unique Web-based participatory health communication method has resulted in a reduction of at-risk alcohol use between baseline and 3 months. The Hello Sunday Morning blog program asks participants to publicly set a personal goal to stop drinking or reduce their consumption for a set period of time, and to record their reflections and progress on blogs and social networks. Daybreak is Hello Sunday Morning's evidence-based behavior change program, which is designed to support people looking to change their relationship with alcohol.

OBJECTIVE

This study aims to systematically evaluate different versions of Hello Sunday Morning's Daybreak program (with and without coaching support) in reducing at-risk alcohol use.

METHODS

We will use a between groups randomized control design. New participants enrolling in the Daybreak program will be eligible to be randomized to receive either (1) the Daybreak program, including peer support plus behavioral experiments (these encourage and guide participants in developing new skills in the areas of mindfulness, connectedness, resilience, situational strategies, and health), or (2) the Daybreak program, including the same peer support plus behavioral experiments, but with online coaching support. We will recruit 467 people per group to detect an effect size of f=0.10. To be eligible, participants must be resident in Australia, aged ≥18 years, score ≥8 on the alcohol use disorders identification test (AUDIT), and not report prior treatment for cardiovascular disease.

RESULTS

The primary outcome measure will be reduction in the AUDIT-Consumption (AUDIT-C) scores. Secondary outcomes include mental health (Kessler's K-10), days out of role (Kessler), alcohol consumed (measured with a 7-day drinking diary in standard 10 g drinks), and alcohol-related harms (CORE alcohol and drug survey). We will collect data at baseline and 1, 3, and 6 months and analyze them with random effects models, given the correlated data structure.

CONCLUSIONS

A randomized trial is required to provide robust evidence of the impact of the online coaching component of the Daybreak program, including over an extended period.

TRIAL REGISTRATION

Australian New Zealand Clinical Trials Registry ACTRN12618000010291; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373110 (Archived by WebCite at http://www.webcitation.org/6zKRmp0aC).

REGISTERED REPORT IDENTIFIER

RR1-10.2196/9982.

摘要

背景

在许多国家,危险饮酒模式普遍存在,给个人、家庭和社会带来了巨大成本。筛查和简短干预措施,包括通过网络实施,是有效的,但迄今为止在实际应用中仍很有限。之前对“周日早安你好”方法的观察性研究发现,其独特的基于网络的参与式健康传播方法已使基线至3个月期间的危险饮酒行为有所减少。“周日早安你好”博客项目要求参与者公开设定个人目标,在一段时间内戒酒或减少饮酒量,并在博客和社交网络上记录他们的思考和进展。“破晓”是“周日早安你好”基于证据的行为改变项目,旨在支持那些希望改变与酒精关系的人。

目的

本研究旨在系统评估“周日早安你好”的“破晓”项目的不同版本(有无辅导支持)在减少危险饮酒方面的效果。

方法

我们将采用组间随机对照设计。报名参加“破晓”项目的新参与者将有资格被随机分配接受以下两种方式之一:(1)“破晓”项目,包括同伴支持和行为实验(这些鼓励并指导参与者在正念、人际关系、适应力、情境策略和健康等领域培养新技能);(2)“破晓”项目,包括相同的同伴支持和行为实验,但有在线辅导支持。我们将每组招募467人,以检测效应量f = 0.10。符合条件的参与者必须居住在澳大利亚,年龄≥18岁,酒精使用障碍识别测试(AUDIT)得分≥8,且未报告有心血管疾病的既往治疗史。

结果

主要结局指标将是AUDIT-消费(AUDIT-C)得分的降低。次要结局包括心理健康(凯斯勒K-10量表)、失能天数(凯斯勒量表)、饮酒量(用标准10克饮料的7天饮酒日记测量)以及与酒精相关的危害(CORE酒精和药物调查)。鉴于数据结构的相关性,我们将在基线、1个月、3个月和6个月收集数据,并使用随机效应模型进行分析。

结论

需要进行一项随机试验,以提供关于“破晓”项目在线辅导部分影响的有力证据,包括长期影响。

试验注册

澳大利亚新西兰临床试验注册中心ACTRN12618000010291;https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373110(由WebCite存档于http://www.webcitation.org/6zKRmp0aC)。

注册报告识别码

RR1-10.2196/9982。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e057/6002672/485abd33dc52/resprot_v7i5e148_fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验